This page lists cancer drugs approved by the Food and Drug Administration (FDA) for soft tissue sarcoma. The list includes generic names and brand names. The drug names link to NCI’s Cancer Drug Information summaries. There may be drugs used in soft tissue sarcoma that are not listed here.
Drugs Approved for Soft Tissue Sarcoma
- Afamitresgene Autoleucel
- Atezolizumab
- Atezolizumab and Hyaluronidase-tqjs
- Cosmegen (Dactinomycin)
- Dactinomycin
- Doxorubicin Hydrochloride
- Eribulin Mesylate
- Fyarro (Sirolimus Protein-Bound Particles)
- Gleevec (Imatinib Mesylate)
- Halaven (Eribulin Mesylate)
- Imatinib Mesylate
- Pazopanib Hydrochloride
- Sirolimus Protein-Bound Particles
- Tazemetostat Hydrobromide
- Tazverik (Tazemetostat Hydrobromide)
- Tecelra (Afamitresgene Autoleucel)
- Tecentriq (Atezolizumab)
- Tecentriq Hybreza (Atezolizumab and Hyaluronidase-tqjs)
- Trabectedin
- Votrient (Pazopanib Hydrochloride)
- Yondelis (Trabectedin)
Drug Combinations Used in Soft Tissue Sarcoma
